Virginia Commonwealth University

Running trials

• Not yet recruiting

  Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

  NCT05936931· Source

• Not yet recruiting

  Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury

  NCT07772323· Source

• Not yet recruiting

  Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

  NCT05974644· Source

• Recruiting

  Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

  NCT07710534· Phase 2· Source

• Not yet recruiting

  Rethinking Early Airway Clearence Therapies

  NCT07696338· Source

• Not yet recruiting

  Colon Health Champion Program

  NCT07796334· Source

• Not yet recruiting

  Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)

  NCT07013396· Source

• Not yet recruiting

  Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy

  NCT07639086· Phase 2· Source

• Recruiting

  Autonomic and Renal Contributions to Hypertension With ADT

  NCT07848828· Phase 4· Source

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Source

• Recruiting

  A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  NCT07143968· Phase 2· Source

• Recruiting

  Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  NCT07224360· Phase 2· Source

• Recruiting

  Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  NCT07227298· Phase 1/2· Source

• Recruiting

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· Phase 2/3· Source

• Recruiting

  Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

  NCT07284290· Phase 4· Source

• Recruiting

  Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

  NCT06794229· Phase 2· Source

• Enrolling by invitation

  Novel On-body Evaluation of Cardiac Health for Oncology

  NCT07158450· Source

• Recruiting

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· Phase 2/3· Source

• Recruiting

  Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

  NCT06745908· Phase 3· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Source

• Recruiting

  Enhancing Oral Cancer Awareness

  NCT06682494· Source

• Recruiting

  Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  NCT06964464· Phase 4· Source

• Recruiting

  Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  NCT06911632· Source

• Active, not recruiting

  P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

  NCT06468033· Phase 3· Source

• Recruiting

  The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

  NCT06854458· Source

• Recruiting

  FearLess in NeuroOncology

  NCT06989086· Source

• Recruiting

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  NCT06846281· Phase 3· Source

• Recruiting

  A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  NCT06944522· Phase 3· Source

• Recruiting

  Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

  NCT06846463· Phase 2· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Source

• Recruiting

  Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  NCT06374238· Source

• Recruiting

  Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

  NCT06728072· Phase 2· Source

• Recruiting

  GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

  NCT06636123· Phase 1· Source

• Recruiting

  Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

  NCT06731413· Phase 2· Source

• Recruiting

  Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  NCT06712355· Phase 3· Source

• Recruiting

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· Source

• Recruiting

  SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

  NCT06743126· Phase 3· Source

• Recruiting

  A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  NCT06562543· Phase 4· Source

• Recruiting

  EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

  NCT06212791· Source

• Recruiting

  Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

  NCT06660355· Phase 2· Source

• Recruiting

  Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  NCT06526195· Source

• Recruiting

  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  NCT06597019· Phase 3· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

  NCT06706674· Phase 3· Source

• Recruiting

  Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  NCT06654752· Source

• Recruiting

  A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  NCT06619561· Phase 2· Source

• Recruiting

  Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

  NCT06370000· Phase 4· Source

• Recruiting

  Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  NCT06541262· Phase 1/2· Source

• Active, not recruiting

  IC14 for Treatment of Acute Decompensated Heart Failure

  NCT06556810· Phase 1/2· Source

• Recruiting

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Source

• Active, not recruiting

  STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

  NCT06571383· Phase 4· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure11 recruiting
• Lung cancer9 recruiting
• Childhood cancers7 recruiting
• Acute myeloid leukemia4 recruiting
• Amyloidosis4 recruiting
• Colorectal cancer4 recruiting
• Cystic fibrosis4 recruiting
• Fatty liver disease (MASLD/MASH)4 recruiting
• High blood pressure4 recruiting
• Prostate cancer4 recruiting
• Multiple myeloma3 recruiting
• Parkinson disease3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Sickle cell disease3 recruiting
• Stroke3 recruiting
• ALS (motor neurone disease)2 recruiting
• Atrial fibrillation2 recruiting
• Autism2 recruiting
• Bipolar disorder2 recruiting
• Endometrial cancer2 recruiting
• Head and neck cancer2 recruiting
• Hepatitis B2 recruiting
• Melanoma2 recruiting
• Neuroblastoma2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Glioblastoma1 recruiting
• HIV1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Lewy body dementia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Pompe disease1 recruiting
• Sarcoma1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  mHealth Intervention for Pain Self Management

  NCT07332377· Source

• Completed

  Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

  NCT06493253· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· Phase 2· Source

• Completed

  Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

  NCT06947395· Source

• Completed

  Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study

  NCT06567925· Source

• Completed

  A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

  NCT06676072· Source

• Completed

  Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

  NCT06688825· Source

• Completed

  Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer

  NCT06947382· Source

• Completed

  CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

  NCT06439420· Phase 2· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Source

• Completed

  Improving Access to Community-Based Occupations Via a Rideshare Training Program

  NCT06323850· Source

• Completed

  Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca

  NCT06250751· Source

• Completed

  The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

  NCT06062966· Phase 1· Source

• Completed

  Feasibility Study: Educational Genetic Test Video

  NCT06166758· Source

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Source

• Completed

  WE Project: 2.0 Grassroots Wellness Coaching (Phase 2)

  NCT06172582· Source

• Completed

  CALM: Managing Distress in Malignant Brain Cancer

  NCT06180460· Source

• Completed

  The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

  NCT05924919· Source

• Completed

  Engaging Black Men in Colorectal Cancer Screening

  NCT05980182· Source

• Completed

  Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management

  NCT05544708· Source

• Terminated

  Antiretroviral Improvement Among Medicaid Enrollees

  NCT05477485· Source

• Recruiting

  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  NCT05727904· Phase 3· Source

• Completed

  Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

  NCT05728866· Source

• Terminated

  A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

  NCT05317078· Phase 1· Source

• Terminated

  Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)

  NCT05605548· Early phase 1· Source

• Completed

  Effect of Parenting With Positive Interven on Comm Inclusion for Military Connected and Dependents With Autism

  NCT05580432· Source

• Withdrawn

  Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

  NCT05130346· Source

• Completed

  ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

  NCT05081245· Phase 2· Source

• Completed

  Vitamin E Dosing Study

  NCT04801849· Phase 2· Source

• Completed

  Istradefylline for Parkinson Disease With Cognitive Impairment

  NCT05333549· Phase 2· Source

• Completed

  Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

  NCT05225415· Phase 2· Source

• Completed

  A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

  NCT05348785· Phase 2· Source

• Completed

  Defining Endpoints in Becker Muscular Dystrophy

  NCT05257473· Source

• Terminated

  Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

  NCT05263492· Phase 2· Source

• Completed

  A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

  NCT05198804· Phase 1/2· Source

• Completed

  Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

  NCT05169580· Phase 1· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  The PROMISE Pediatric Study 6 to 11 Years Old

  NCT04613128· Source

• Completed

  SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting

  NCT04746846· Source

• Completed

  CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

  NCT05130606· Source

• Completed

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· Phase 2· Source

• Completed

  Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

  NCT04697628· Phase 3· Source

• Completed

  Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

  NCT04463771· Phase 2· Source

• Completed

  Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

  NCT04609566· Phase 2· Source

• Completed

  LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

  NCT04577807· Phase 2· Source

• Completed

  Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

  NCT04454463· Source

• Completed

  A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

  NCT04596631· Phase 3· Source

• Completed

  A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

  NCT04489888· Phase 4· Source

• Completed

  Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

  NCT04266197· Phase 2· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Source

Trial sites

• Virginia Commonwealth University1 trial
• Virginia Commonwealth Univ2 trials
• Virginia Commonwealth University196 trials
• Virginia Commonwealth University - Department of Internal Medicine1 trial
• Virginia Commonwealth University Department of Neurology1 trial
• Virginia Commonwealth University_Richmond1 trial
• Virginia Commonwealth University School of Medicine7 trials
• Virginia Commonwealth University (Site 0024)1 trial
• Virginia Commonwealth University (Site 0233)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure100 works · 18 trials
• Fatty liver disease (MASLD/MASH)99 works · 17 trials
• Parkinson disease49 works · 6 trials
• Cystic fibrosis36 works · 8 trials
• Depression36 works · 0 trials
• Triple-negative breast cancer33 works · 0 trials
• Schizophrenia31 works · 1 trials
• Sickle cell disease27 works · 9 trials
• Bipolar disorder27 works · 2 trials
• Acute myeloid leukemia22 works · 6 trials
• Long COVID and ME/CFS12 works · 0 trials
• Myasthenia gravis11 works · 2 trials
• Lewy body dementia5 works · 2 trials
• High blood pressure4 works · 5 trials